1:00 |
126 |
Eckerle |
Deregulated Rb-E2F Mediates Elevated Survivin Expression in Aggressive Neuroblastomas |
1:15 |
127 |
Bansal |
Expression Profiling Identifies BAI2, an Endogenous Inhibitor of Angiogenesis, as a Target for Somatic Inactivation in High-Risk Neuroblastoma |
1:30 |
128 |
Kitlinska |
Neuropeptide Y A Novel Growth Factor for Neuroblastoma |
1:45 |
129 |
Das |
The Role of VEGF/Flt1 Signaling in Maintenance of Neuroblastoma Side-Population Cell "Stemness" during Hypoxia |
2:00 |
130 |
Jackson |
Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression Via Hypoxia-Inducible Factor-1α in Neuroblastoma Cells and Mouse Normal Nerve Cells |
2:15 |
131 |
Bajou |
Proangiogenic Function of Plasminogen Activator Inhibitor-1 (PAI-1) in Neuroblastoma Angiogenesis: PAI-1 Protects Endothelial Cells from FasL-Induced Apoptosis |
2:30 |
132 |
Dickson |
Bevacizumab-Induced Vascular Normalization |
2:45 |
133 |
Song |
MYCN Oncogene Regulates CCL2 Expression and Localization of Natural Killer T Cells in Neuroblastoma |
3:00 |
134 |
Pajtler |
Expression of TrkA Is a Potential Regulator of Immunogenicity in Neuroblastoma Cells |
3:15 |
135 |
Simpson |
Significance of TrkAIII Isoform Expression in Human Neuroblastoma |
3:30 |
136 |
Chesler |
Inhibition of the PI3-Kinase Pathway Blocks Malignant Progression of Neuroblastoma In-Vivo, by Destabilizing Mycn Protein |
3:45 |
137 |
Pistoia |
Tumor Origin of Endothelial Cells in Human Neuroblastoma |
4:00 |
Break |
|
|
